NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors

oleh: Nicolas Duployez, Guillaume Grzych, Benoît Ducourneau, Martin Alarcon Fuentes, Nathalie Grardel, Thomas Boyer, Wadih Abou Chahla, Bénédicte Bruno, Brigitte Nelken, Emmanuelle Clappier, Claude Preudhomme

Format: Article
Diterbitkan: Ferrata Storti Foundation 2016-04-01

Deskripsi

No description available for this item.